Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa Long-term Safety and Efficacy Follow-up of BIIB111for the Treatment of Choroideremia and BIIB112 for ...
A Long-term Follow-up Study to Evaluate the Safety and Efficacy of Retinal Gene Therapy in Subjects With Choroideremia Previously Treated With Adeno-Associated Viral Vector Encoding Rab Escort Protein-1 (AAV2-REP1) and in Subjects With X-Linked Retinitis Pigmentosa Previously Treated With Adeno-Associated Viral Vector Encoding RPGR (AAV8-RPGR) in an Antecedent Study A Long-term Follow-up Study to Evaluate the Safety and Efficacy of Retinal Gene Therapy in Subjects ...
Choroideremia;X-Linked Retinitis Pigmentosa
Genetic: BIIB111;Genetic: BIIB112
NightstaRx Ltd, a Biogen Company
NULL
Enrolling by invitation
10 Years
N/A
Male
440
Phase 3
United States;Brazil;Canada;Denmark;Finland;France;Germany;Netherlands;United Kingdom